Page 3 - Morphosys Development Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ( MorphoSys ), announces today that it has entered into a definitive agreement with Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) ( Constellation ) whereby MorphoSys will acquire Constellation for $34.00 per share in cash, which represents a total equity value of $1.7 billion. The transaction has been unanimously approved by the Management Board ( Vorstand) and the Supervisory Board ( Aufsichtsrat) of MorphoSys, as well as the Board of Directors of Constellation and is expected to close in the third quarter of 2021.

United statesUnited kingdomJulia neugebauerNovarti promactaMyles cloustonMerck januviaDevelopment funding bondsJanssen biotech incMorphosys development incDrug administrationConstellation pharmaceuticals incJanssen research developmentMorphosys us incFrankfurt stock exchangeExchange commissionMillion development funding bonds